BBC ETF (Virtus LifeSci Biotech Clinical Trials ETF) is managed by Virtus Investment Partners with $38.7M in net assets. BBC expense ratio is 0.79%, holding 127 positions across sectors including Health Care, Unknown, Industrials. Inception date: 2014-12-16.

BBC performance shows a YTD return of 12.33%. The 1-year return is 111.82% and the 5-year return is -4.28%. BBC dividend yield stands at 1.54%, paid annually.

BBC top holdings include Ventyx Biosciences Inc (1.4%), Erasca Inc. (1.3%), Alumis Inc (1.3%), Monte Rosa Therapeutics Inc. (1.3%), Enliven Therapeutics Inc (1.1%). View all BBC holdings, sector breakdown, or dividend history.

BBC can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBC alternatives are available via the screener, along with tax-loss harvesting opportunities.